MCHR1 and obesity due to melanocortin 4 receptor deficiency: Mchr1 antagonists inhibit food intake, reduced consumption of palatable food, and, after chronic administration to rats with diet-induced obesity, resulted in a decrease in body weight (reviewed in [29]).